Amy Hanlon Newell
Overview
Explore the profile of Amy Hanlon Newell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang R, Smith D, Le C, Liu W, Ordinario E, Manohar C, et al.
Arch Pathol Lab Med
. 2019 Sep;
144(6):735-741.
PMID: 31509456
Context.—: The ability to determine status has become mandatory for patients with lung adenocarcinoma, as many global authorities have approved crizotinib for patients with -positive lung adenocarcinoma. Objective.—: To present...
2.
Lobo J, Petronilho S, Newell A, Coach J, Harlow G, Cruz A, et al.
Mod Pathol
. 2019 Jun;
32(11):1574-1586.
PMID: 31231125
Breast cancer is a heterogeneous disease and additional biomarkers for individually predicting patient outcomes are needed. Aberrant membrane E-cadherin immunoexpression has been demonstrated in lobular breast cancer. Also, E-cadherin nuclear...
3.
Calhoun B, Mosteller B, Warren D, Smith M, Rowe J, Lanigan C, et al.
Ann Diagn Pathol
. 2018 May;
35:21-26.
PMID: 29758480
Objective: Comparison of analytical and immunohistochemical performance of progesterone receptor (PR) antibodies with correlation to recurrence of invasive breast cancer treated with endocrine therapy. Methods: The binding-affinity kinetics of PR...
4.
Owen N, Hejna J, Rennie S, Mitchell A, Newell A, Ziaie N, et al.
Cytogenet Genome Res
. 2015 Mar;
144(4):255-263.
PMID: 25766002
Biallelic mutations in BLM cause Bloom syndrome (BS), a genome instability disorder characterized by growth retardation, sun sensitivity and a predisposition to cancer. As evidence of decreased genome stability, BS...
5.
Luoh S, Ramsey B, Newell A, Troxell M, Hu Z, Chin K, et al.
Springerplus
. 2013 Oct;
2:386.
PMID: 24102037
Background: Testing for human epidermal growth factor receptor-2 (HER-2) in breast cancer is performed by either immunohistochemistry (IHC) or in situ hybridization (ISH). The growth factor receptor-bound protein-7 (GRB7) gene...
6.
Kumari A, Lim Y, Newell A, Olson S, McCullough A
DNA Repair (Amst)
. 2011 Dec;
11(3):236-46.
PMID: 22186232
Formaldehyde is a reactive chemical that is commonly used in the production of industrial, laboratory, household, and cosmetic products. The causal association between formaldehyde exposure and increased incidence of cancer...
7.
Ramsey B, Bai T, Newell A, Troxell M, Park B, Olson S, et al.
Breast Cancer Res Treat
. 2010 Jul;
127(3):659-69.
PMID: 20635137
The growth factor receptor-bound protein-7 gene (GRB7) encodes a multi-domain signal transduction molecule. The purpose of this study was to examine the clinical significance of GRB7 protein expression in human...
8.
Bumm T, Deininger J, Newell A, Lawce H, Olson S, Mauro M, et al.
Leukemia
. 2010 Jun;
24(8):1525-1528.
PMID: 20535153
No abstract available.
9.
van de Vrugt H, Eaton L, Newell A, Al-Dhalimy M, Liskay R, Olson S, et al.
Cancer Res
. 2009 Nov;
69(24):9431-8.
PMID: 19934329
DNA repair defects are frequently encountered in human cancers. These defects are utilized by traditional therapeutics but also offer novel cancer treatment strategies based on synthetic lethality. To determine the...